Click here to read the articles and download the PDF

Pharmaceutical Commerce - December 2024

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Did Industry Fumble the DSCSA Deadline?

A crash course on the bubble itself, including therapeutic areas most affected.

Going Inside the Gross-to-Net Bubble and Its Nuances

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Why AI Advances in CGT Require Getting Data Right

Articles

The latest news for pharma industry insiders.

Pharma Pulse 12/18/24: The Art of Cross-Cultural Communication in Pharma, The Role of a Digital Navigator in Mental Health & more

Videos

Cheryl Allen, BS Pharm, MBA, founding partner, Curatio Scientia Advisors, discusses "Enhancing Patient Access and Support Through Technology: A Comprehensive Assessment," and upcoming industry challenges.  

Trade & Channel Strategies 2024: Boosting Patient Support & Engagement Across Care Settings

The 430,000 square-foot finished production facility will house multiple product types within the rare disease sector, including hemophilia. 

Novo Nordisk Financially Commits $1.2 Billion Toward New Danish Production Plant

Pharma Pulse 12/17/24: Key Markets Investors Can’t Ignore, Researchers Link Specific Protein to Diabetic Cardiomyopathy & more

A panel examines the gross-to-net bubble across various product mixes, how pricing impacts market access, and more.  

Trade & Channel Strategies 2024: A GTN Bubble Balancing Act

Kevin O’Meara discusses how patient service teams influence adherence from Direct-to-Patient models. 

Trade & Channel Strategies 2024: The Role of Patient Service Teams in Driving Direct-to-Patient Adherence

Pharma Pulse 12/16/24: Dark Chocolate Lowers T2D Risk, Technology Accessibility & more

In the fourth part of this roundtable discussion, key opinion leaders discuss how successful RFID use cases in the food sector can translate well to pharma, including what needs to be implemented in order to see success. 

Peer Exchange: Learning from Other Industries (Episode 4)

Bill Trombetta, PhD, professor, healthcare strategy, marketing, St. Joseph's University, discusses the breakout session at Trade & Channel Strategies in Philadelphia.

Trade & Channel Strategies 2024: Industry Audit—Analyzing Top Biopharmaceuticals Performance Metrics

A session provides considerations for manufacturers during development, rollouts, and implementation, specifically as it pertains to the HSSP perspective.  

Featured Content

Pharmaceutical Commerce - December 2024

Did Industry Fumble the DSCSA Deadline?

Going Inside the Gross-to-Net Bubble and Its Nuances

Why AI Advances in CGT Require Getting Data Right